These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 16716414

  • 21. Therapy of hepatitis B -- viral suppression or eradication?
    Perrillo RP.
    Hepatology; 2006 Feb; 43(2 Suppl 1):S182-93. PubMed ID: 16447260
    [Abstract] [Full Text] [Related]

  • 22. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [Abstract] [Full Text] [Related]

  • 23. Pathobiology of HBV mutants and clinical impact for treatment monitoring.
    Si Ahmed SN, Zoulim F.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):309-20. PubMed ID: 19344244
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Feld JJ, Heathcote EJ.
    Semin Liver Dis; 2006 May; 26(2):116-29. PubMed ID: 16673290
    [Abstract] [Full Text] [Related]

  • 25. [The patient with uncontrolled chronic hepatitis B].
    Zarski JP, Leroy V.
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt 2):S7-11. PubMed ID: 18662613
    [Abstract] [Full Text] [Related]

  • 26. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Zoulim F.
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
    [No Abstract] [Full Text] [Related]

  • 27. [Entecavir therapy against hepatitis B].
    Kato N, Omata M.
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
    [No Abstract] [Full Text] [Related]

  • 28. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
    Bronowicki JP, Barraud H, Couzigou P.
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
    [No Abstract] [Full Text] [Related]

  • 29. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 30. Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.
    Price N, Boxall EH.
    J Antimicrob Chemother; 2007 Dec 10; 60(6):1189-92. PubMed ID: 17913721
    [Abstract] [Full Text] [Related]

  • 31. [A primer on the management of antiviral resistance in chronic hepatitis B].
    Doerig C, Sahli R, Telenti A, Moradpour D.
    Rev Med Suisse; 2009 Jan 21; 5(187):203-4, 206-8,. PubMed ID: 19271431
    [Abstract] [Full Text] [Related]

  • 32. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
    Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, Ghany MG, Pawlotsky JM, Liaw YF, Mizokami M, Kuiken C, Hepatitis B Virus Drug Resistance Working Group.
    Hepatology; 2007 Jul 21; 46(1):254-65. PubMed ID: 17596850
    [Abstract] [Full Text] [Related]

  • 33. [The genetic variability and clinical significance of hepatitis B virus].
    Tang H, Chen EQ.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar 21; 17(3):161-3. PubMed ID: 19554777
    [No Abstract] [Full Text] [Related]

  • 34. Management and prevention of drug resistance in chronic hepatitis B.
    Zoulim F, Durantel D, Deny P.
    Liver Int; 2009 Jan 21; 29 Suppl 1():108-15. PubMed ID: 19207973
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B therapies and antiviral resistance detection and management.
    Holness G, Carriero DC, Dieterich DT.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 21; 3(6):693-9. PubMed ID: 19929588
    [Abstract] [Full Text] [Related]

  • 36. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA.
    Eksp Klin Gastroenterol; 2007 Dec 21; (2):107-12. PubMed ID: 17539354
    [No Abstract] [Full Text] [Related]

  • 37. [Management of chronic viral hepatitis].
    Pache I, Mondada D, Moradpour D, Fontana M.
    Rev Med Suisse; 2007 Jan 24; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [Abstract] [Full Text] [Related]

  • 38. Treatment of chronic hepatitis B.
    Loomba R, Liang TJ.
    Antivir Ther; 2007 Jan 24; 12 Suppl 3():H33-41. PubMed ID: 18284181
    [Abstract] [Full Text] [Related]

  • 39. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP, Soriano V, Zeuzem S.
    Handb Exp Pharmacol; 2009 Jan 24; (189):321-46. PubMed ID: 19048206
    [Abstract] [Full Text] [Related]

  • 40. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O, Parvaz P, Bouix C, Chevallier P, Trépo C, André P, Zoulim F.
    J Med Virol; 2009 Aug 24; 81(8):1336-42. PubMed ID: 19551826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.